Fever is one of the pathophysiological symptoms accompanying the response of the host to infection and inflammation. Although the adaptive value of the fever response has been well documented in laboratory studies, its role in clinical medicine is still under debate. Two of the hypotheses studied state that endogenous mediators of fever may be involved in establishing the Th1 immunologic phenotype of the host and in improving general immunologic surveillance. It is known that these factors play a significant role in defence against tumour cells. Therefore, in the present study we tested the hypothesis that patients diagnosed with cancer reveal a history of fewer fevers during the disease than control, healthy volunteers. 18 questions were asked concerning the history of fever prior to diagnosis from 355 persons suffering from cancer, and 244 healthy controls, matched for age and living in Poland. Cancer patients reported a lower incidence of fever during illness than controls. The percentage of cancer patients and controls who reported no fever during infections was 83.10% and 56.97%, respectively. Similarly, 16.90% of cancer patients and 43.03% of controls reported always experiencing fever during infections. The results of our study support the hypothesis that during their lifetime cancer patients experience less fever during infection than healthy controls.
Kozak W, Wrotek S, Walentynowicz K, Waszak P: Fever and symptoms of sickness are present in mice lacking functional B and T lymphocytes. Acta Biol Cracov 2006, 48, 9-20.
Moesby L, Hansen EW, Christensen JD, Tommerup L, Nielsen C: Endospores of B. subtilis are pyrogenic and activate Mono Mac 6 cells: importance of the CD14 receptor. Eur J Pharm Sci 2003, 19, 245-251.
Kozak, W, Wrotek S, Kozak A: Pyrogenicity of CpG-DNA in mice: Role of interleukin-6, cyclooxygenases, and nuclear-factor-kappa-B. Am J Physiol Regul Integr Comp Physiol 2006, 290, 871-880.
Roberts Jr NJ: The immunological consequences of fever. In: Mackowiak PA (ed.), Fever: Basic Mechanisms and Management. Raven Press, New York 1991, 125.
Van Steensel-Moll HA, Valkenburg HA, van Zanen GE: Childhood leukemia and infectious disease in the fi rst year of life: A register based case-control study. Am J Epidemiol 1986, 124, 590-594.
Abel U, Becker N, Angerer N, Frentzel-Beyme R, Kaufmann M, Schlag P, Wysocki S, Wherdorf J, Schultz G: Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991, 117, 339-344.
Albonico HU, Braker HU, Husler J: Febrile infectious childhood diseases in the history of cancer patients and matched controls. Med Hypoth 1998, 51, 315–320.
Hoff man C, Rosenberger A, Troger W, Buhring M: Childhood diseases, infectious diseases, and fever as potential risk factors for cancer? Forsch Komplement Klass Naturheilkd 2002, 9, 324–330.
Lienard D, Ewalenko P, Delmotte JJ, Renard N and Lejeune FJ: Highdose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992, 10, 52-60.
Yang JC, Topalian SL, Parkinson D, Schwartzentruber DJ, Weber JS, Ettinghausen SE, White DE, Steinberg SM, Cole DJ, Kim HI, et al.: Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report. J Clin Oncol 1994, 12, 1572-1576.
Mastrangelo G, Fadda E, Milan G: Cancer increased after a reduction of infections in the fi rst half of this century in Italy: etiologic and preventive implications, Eur J Epidemiol 1998, 14, 749–754.
Mackersen A, Galanos C, Engelhardt T: Treatment of cancer patients with endotoxin induces release of endogenous cytokines. Pathobiology 1991, 59, 264-267.
Goto S, Sakai S, Kera J, Suma Y, Soma GI, Takeuchi S: Intradermal administration of liposaccharyde in treatment of human cancer. Cancer Immunol Immunother 1996, 42, 255-261.
The Journal of Pre-Clinical and Clinical Research welcomes article submissions and does not charge a publication fee. Submit your article today and gain worldwide visibility for your article.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.